INS and type 2 diabetes mellitus: In the case of the IGF2BP2 gene, the identified T2DM-specific SNP could attenuate both islet enhancer activity and IGF2BP2 expression, and the islet-specific conditional deficiency of Igf2bp2 gene led to impaired glucose-induced insulin secretion in mice [176].